Li TAN, Gui-li ZHOU, Meng-hua DAI, Zhi-lan MENG, Yang GUI, Meng-su XIAO, Jing ZHANG, Qing ZHANG, He LIU, Hua MENG, Jian-chu LI, Ke LYU. Evaluation of Percutaneous Ultrasound-guided Biopsy for Pancreatic Neoplasms: A Case-control Study[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(3): 289-295. DOI: 10.3969/j.issn.1674-9081.20190209
Citation: Li TAN, Gui-li ZHOU, Meng-hua DAI, Zhi-lan MENG, Yang GUI, Meng-su XIAO, Jing ZHANG, Qing ZHANG, He LIU, Hua MENG, Jian-chu LI, Ke LYU. Evaluation of Percutaneous Ultrasound-guided Biopsy for Pancreatic Neoplasms: A Case-control Study[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(3): 289-295. DOI: 10.3969/j.issn.1674-9081.20190209

Evaluation of Percutaneous Ultrasound-guided Biopsy for Pancreatic Neoplasms: A Case-control Study

More Information
  • Corresponding author:

    LYU Ke  Tel:lvke@163.com

  • Received Date: October 03, 2019
  • Issue Publish Date: May 29, 2020
  •   Objective  This study aimed to evaluate the diagnostic value of percutaneous ultrasound-guided (US-guided) biopsy for pancreatic neoplasms, and to compare the evaluation of fine needle aspiration(FNA) and core needle biopsy (CNB).
      Methods  Data of consecutive patients who had percutaneous US-guided biopsies of pancreatic masses for the diagnosis of suspiciously malignant solid pancreatic masses in Peking Union Medical College Hospital between January 2014 and April 2017 were retrospectively analyzed. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy were evaluated based on the biopsy methods (FNA vs. CNB). The final diagnosis was determined according to a combination of follow-up (no shorter than 6 months) imaging, clinical course evaluation, repeated biopsy and/or surgical pathology.
      Results  A total of 160 patients who met the inclusion and exclusion criteria were enrolled in this study, including 95 in the FNA group and 65 in the CNB group. The overall sensitivity, specificity, PPV, NPV, and accuracy of percutaneous US-guided biopsy were 93.8%, 100%, 100%, 64.0%, and 94.4%, respectively. The sensitivity, NPV, and accuracy of the CNB group were higher than those of FNA group (94.7% vs. 93.1%,72.7% vs. 57.1%,95.4% vs. 93.7%), but there was no statistical difference between the two groups. Two cases with major complications (1.3%, 2/160) were observed, including one acute pancreatitis and one tumor seeding.
      Conclusions  Percutaneous US-guided biopsy is an effective and safe diagnostic method for pancreatic neoplasms. The current data do not suggest significant differences in the diagnostic efficacy of FNA and CNB.
  • [1]
    D'Onofrio M, Beleù A, De Robertis R. Ultrasound-guided percutaneous procedures in pancreatic diseases:new techniques and applications[J]. Eur Radiol Exp, 2019, 3:2. DOI: 10.1186/s41747-018-0081-2
    [2]
    Pitman MB, Layfield LJ, Guidelines for pancreaticobiliary cytology from the Papanicolaou Society of Cytopathology:A review[J]. Cancer Cytopathol, 2014, 122:399-411. DOI: 10.1002/cncy.21427
    [3]
    Layfield LJ, Schmidt RL, Hirschowitz SL, et al. Signific-ance of the diagnostic categories "atypical" and "suspicious for malignancy" in the cytologic diagnosis of solid pancreatic masses[J]. Diagn Cytopathol, 2014, 42:292-296. DOI: 10.1002/dc.23078
    [4]
    D'Onofrio M, De Robertis R, Barbi E, et al. Ultrasound-guided percutaneous fine-needle aspiration of solid pancreatic neoplasms:10-year experience with more than 2,000 cases and a review of the literature[J]. Eur Radiol, 2016, 26:1801-1807. DOI: 10.1007/s00330-015-4003-x
    [5]
    Erturk SM, Silverman S, Mortele K, et al. Percutaneous biopsy of abdominal masses using 25-gauge needles[J]. Abdom Imaging, 2010, 35:70-74. DOI: 10.1007/s00261-008-9492-5
    [6]
    Yang RY, Ng D, Jaskolka JD, et al. Evaluation of percutaneous ultrasound-guided biopsies of solid mass lesions of the pancreas:a center's 10-year experience[J]. Clin Imaging, 2015, 39:62-65. DOI: 10.1016/j.clinimag.2014.06.010
    [7]
    Suzuki R, Irisawa A, Bhutani MS, et al. Prospective evaluation of the optimal number of 25-gauge needle passes for endoscopic ultrasound-guided fine-needle aspiration biopsy of solid pancreatic lesions in the absence of an onsite cytopathologist[J]. Dig Endosc, 2012, 24:452-456. DOI: 10.1111/j.1443-1661.2012.01311.x
    [8]
    Jang DK, Lee SH, Lee JK, et al. Comparison of cytological and histological preparations in the diagnosis of pancreatic malignancies using endoscopic ultrasound-guided fine needle aspiration[J]. Hepatob Pancreat Dis, 2017, 16:418-423. DOI: 10.1016/S1499-3872(17)60035-3
    [9]
    Qin SY, Zhou Y, Li P, et al. Diagnostic efficacy of cell block immunohistochemistry, smear cytology, and liquid-based cytology in endoscopic ultrasound-guided fine-needle aspiration of pancreatic lesions:a single-institution experi-ence[J]. PLoS One, 2014, 9:e108762. DOI: 10.1371/journal.pone.0108762
    [10]
    Itonaga M, Murata SI, Hatamaru K, et al. Diagnostic efficacy of smear plus liquid-based cytology for EUS-FNA of solid pancreatic lesions:A propensity-matched study[J]. Medicine (Baltimore), 2019, 98:e15575. DOI: 10.1097/MD.0000000000015575
    [11]
    Samir AE, Vij A, Seale MK, et al. Ultrasound-guided percutaneous thyroid nodule core biopsy:clinical utility in patients with prior nondiagnostic fine-needle aspirate[J]. Thyroid, 2012, 22:461-467. DOI: 10.1089/thy.2011.0061
    [12]
    Yeon JS, Baek JH, Lim HK, et al. Thyroid nodules with initially nondiagnostic cytologic results:the role of core-needle biopsy[J]. Radiology, 2013, 268:274-280. DOI: 10.1148/radiol.13122247
    [13]
    Huang Y, Shi J, Chen YY, et al. Ultrasound-Guided Percutaneous Core Needle Biopsy for the Diagnosis of Pancreatic Disease[J]. Ultrasound Med Biol, 2018,44:1145-1154. DOI: 10.1016/j.ultrasmedbio.2018.02.016
    [14]
    Di SM, Lencioni R, Solmi L, et al. Ultrasound-Guided Fine Needle Biopsy of Pancreatic Masses:Results of a Multicenter Study[J]. Am J Gastroenterol, 1998, 93:1329-1333. DOI: 10.1111/j.1572-0241.1998.443_m.x
    [15]
    Paulsen SD, Nghiem HV, Negussie E, et al. Evaluation of imaging-guided core biopsy of pancreatic masses[J]. AJR Am J Roentgenol, 2006, 187:769-772. DOI: 10.2214/AJR.05.0366
    [16]
    Kahriman G, Ozcan N, Dogan S, et al. Percutaneous ultrasound-guided core needle biopsy of solid pancreatic masses:Results in 250 patients[J]. J Clin Ultrasound, 2016, 44:470-473. DOI: 10.1002/jcu.22362
    [17]
    Zech CJ, Helmberger T, Wichmann MW, et al. Large core biopsy of the pancreas under CT fluoroscopy control:results and complications[J]. J Comput Assist Tomogr, 2002, 26:743-749. DOI: 10.1097/00004728-200209000-00014
    [18]
    Karlson BM, Forsman CA, Wilander E, et al. Efficiency of percutaneous core biopsy in pancreatic tumor diagnosis[J]. Surgery, 1996, 120:75-79. DOI: 10.1016/S0039-6060(96)80244-3
    [19]
    Matsubara J, Okusaka T, Morizane C, et al. Ultrasound-guided percutaneous pancreatic tumor biopsy in pancreatic cancer:a comparison with metastatic liver tumor biopsy, including sensitivity, specificity, and complications[J]. J. Gastroenterol, 2008, 43:225-232. DOI: 10.1007/s00535-007-2142-9
    [20]
    Zamboni GA, D'Onofrio M, Idili A, et al. Ultrasound-guided percutaneous fine-needle aspiration of 545 focal pancreatic lesions[J]. AJR Am J Roentgenol, 2009, 193:1691-1695. DOI: 10.2214/AJR.09.2958
    [21]
    Caturelli E, Rapaccini GL, Anti M, et al. Malignant seeding after fine-needle aspiration biopsy of the pancreas[J]. Diagn Imaging Clin Med, 1985, 54:88-91. http://www.ncbi.nlm.nih.gov/pubmed/3886264
    [22]
    Tyng CJ, Almeida MF, Barbosa PN, et al. Computed tomography-guided percutaneous core needle biopsy in pancreatic tumor diagnosis[J]. World J Gastroenterol, 2015, 21:3579-3586. DOI: 10.3748/wjg.v21.i12.3579
    [23]
    Maturen KE, Nghiem HV, Marrero JA, et al. Lack of tumor seeding of hepatocellular carcinoma after percutaneous needle biopsy using coaxial cutting needle technique[J]. AJR Am J Roentgenol, 2006, 187:1184-1187. DOI: 10.2214/AJR.05.1347
    [24]
    Johnson DE, Pendurthi TK, Balshem AM, et al. Implica-tions of fine-needle aspiration in patients with resectable pancreatic cancer[J]. Am Surg, 1997, 63:675-679; discussion 679-680. http://europepmc.org/abstract/MED/9247432
    [25]
    Hernandez LV, Bhutani MS, Eisner M, et al. Non-surgical tissue biopsy among patients with advanced pancreatic cancer:effect on survival[J]. Pancreas, 2009, 38:289-292. DOI: 10.1097/MPA.0b013e318192eb9b
  • Related Articles

    [1]TIAN Xinping, ZHAO Jiuliang, LI Mengtao, SONG Yijun, LIU Juntao, ZENG Xiaofeng. Interpretation on the 2022 Chinese Guideline for the Management of Pregnancy and Reproduction in Patients with Systemic Lupus Erythematous[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 504-513. DOI: 10.12290/xhyxzz.2023-0119
    [2]SHEN Tian, WU Xiaochuan. Systemic Lupus Erythematosus: from Pathogenesis to New Targeted Therapies[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(2): 234-240. DOI: 10.12290/xhyxzz.2022-0694
    [3]WANG Lin, SONG Hongmei. Interpretation on Chinese Guidelines for the Diagnosis and Treatment of Childhood-onset Systemic Lupus Erythematosus[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(3): 412-420. DOI: 10.12290/xhyxzz.2022-0018
    [4]Jiang-hong DENG, Cai-feng LI. Improving the Acknowledge of Childhood-onset Systemic Lupus Erythematosus[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(3): 276-282. DOI: 10.3969/j.issn.1674-9081.20200069
    [5]Yang CUI, Xiao ZHANG. Comprehensive Management of Systemic Lupus Erythematosus During Pregnancy[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(3): 270-275. DOI: 10.3969/j.issn.1674-9081.20200026
    [6]Bei-di CHEN, Li-dan ZHAO, Xuan ZHANG. Gut Microbiota and Systemic Lupus Erythematosus[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(3): 258-263. DOI: 10.3969/j.issn.1674-9081.20200056
    [7]Nian-sheng YANG. Trends in the Pharmacological Treatment for Systemic Lupus Erythematosus[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(3): 247-251. DOI: 10.3969/j.issn.1674-9081.20200061
    [8]Hua-xia YANG, Feng-chun ZHANG. New Biologic Targets for Systemic Lupus Erythematosus: Hope and Challenge[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(3): 241-246. DOI: 10.3969/j.issn.1674-9081.20200091
    [9]Cheng-mei HE, Feng-chun ZHANG. Belimumab:A New Targeted Drug for Systemic Lupus Erythematosus[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(2): 130-134. DOI: 10.3969/j.issn.1674-9081.20190114
    [10]Yuan XIA, Xiang-pei LI. The Role of MicroRNA Regulation of Interferon-α in the Pathogenesis of Systemic Lupus Erythematosus[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(6): 673-678. DOI: 10.3969/j.issn.1674-9081.2019.06.021

Catalog

    Article Metrics

    Article views (681) PDF downloads (91) Cited by()
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close